| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.097 | 0.03 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.082 | 0.04 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.079 | 0.04 |